AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22565511 — intervention group
Group type: EXPERIMENTAL
Intervention: Sprite with sodium fluoride
Number of subjects: 24
Study 22565511 — intervention group
Group type: EXPERIMENTAL
Intervention: Sprite with calcium phosphate
Number of subjects: 24
Study 22565511 — intervention group
Group type: COMPARATOR
Intervention: Original drink Sprite
Number of subjects: 24
Study 21789881 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg daily oral DHEA for 28 days
Number of subjects: 20
Study 21789881 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA) for 28 days
Number of subjects: 20
Study 18007119 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured strength and balance training (3 times a week for 10 weeks)
Number of subjects: 30
Study 18007119 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 16331852 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate dose of alcohol (0.65 g/kg)
Number of subjects: 20
Study 16331852 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 11815423 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term estrogen administration (25 mg of conjugated equine estrogens IV)
Number of subjects: 54
Study 11815423 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term hormone replacement therapy (HRT)
Number of subjects: 54
Study 11815423 — intervention group
Group type: COMPARATOR
Intervention: Control group (12 young healthy women)
Number of subjects: 54
Study 11815423 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term HRT (estrogen alone or with progestogen)
Number of subjects: 54
Study 11815423 — intervention group
Group type: EXPERIMENTAL
Intervention: Women not taking HRT
Number of subjects: 54
Study 10412515 — intervention group
Group type: EXPERIMENTAL
Intervention: rh-GH therapy (0.250 IU/Kg/week)
Number of subjects: 9
Study 10412515 — intervention group
Group type: EXPERIMENTAL
Intervention: rh-GH therapy
Number of subjects: 9
Study 10412515 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 9
Study 7748051 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibitors
Number of subjects: 14
Study 7748051 — intervention group
Group type: EXPERIMENTAL
Intervention: Nondihydropyridine calcium antagonists
Number of subjects: 14
Study 7748051 — intervention group
Group type: COMPARATOR
Intervention: Dihydropyridine calcium antagonists
Number of subjects: 14
Study 7748051 — intervention group
Group type: COMPARATOR
Intervention: Blood pressure reduction (10 mm Hg)
Number of subjects: 14
Study 1983711 — intervention group
Group type: EXPERIMENTAL
Intervention: silymarin
Number of subjects: 60
Study 1983711 — intervention group
Group type: EXPERIMENTAL
Intervention: amino‐imidazol‐carboxamid‐phosphate
Number of subjects: 60
Study 1983711 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 60
Study 6989556 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous transcutaneous oxygen (PtcO2) monitoring
Number of subjects: 10
Study 6989556 — intervention group
Group type: COMPARATOR
Intervention: Estimation from arterial blood gas (PaO2)
Number of subjects: 10
Study 31454046 — intervention group
Group type: COMPARATOR
Intervention: 400 IU Vitamin D3
Number of subjects: 311
Study 31454046 — intervention group
Group type: EXPERIMENTAL
Intervention: 4000 IU Vitamin D3
Number of subjects: 311
Study 31454046 — intervention group
Group type: EXPERIMENTAL
Intervention: 10,000 IU Vitamin D3
Number of subjects: 311
Study 28776117 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH antagonist (0.25 mg/12 h) administered the day before hCG trigger
Number of subjects: 194
Study 28776117 — intervention group
Group type: COMPARATOR
Intervention: Control group (no double dose of GnRH antagonist)
Number of subjects: 194
Study 25619464 — intervention group
Group type: EXPERIMENTAL
Intervention: Home electrical stimulation (HES)
Number of subjects: 36
Study 25619464 — intervention group
Group type: COMPARATOR
Intervention: Standardized biofeedback training (SBT)
Number of subjects: 36
Study 23809945 — intervention group
Group type: EXPERIMENTAL
Intervention: Wavefront-guided with aspheric ablation
Number of subjects: 31
Study 23809945 — intervention group
Group type: COMPARATOR
Intervention: Aspheric ablation only
Number of subjects: 31
Study 21928117 — intervention group
Group type: COMPARATOR
Intervention: Household Environmental Tobacco Smoke Exposure (HH‐ETSE) among non-smokers
Number of subjects: 929
Study 21928117 — intervention group
Group type: COMPARATOR
Intervention: Current smoking among smokers
Number of subjects: 929
Study 21928117 — intervention group
Group type: COMPARATOR
Intervention: Household Environmental Tobacco Smoke Exposure (HH‐ETSE) as a mediator
Number of subjects: 929
Study 19154566 — intervention group
Group type: EXPERIMENTAL
Intervention: B vitamin supplementation (0.8 mg folic acid, 0.5 mg cyanocobalamin, and 3 mg pyridoxine daily for 6 months)
Number of subjects: 65
Study 19154566 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 17545174 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 56
Study 17545174 — intervention group
Group type: COMPARATOR
Intervention: Diphenhydramine
Number of subjects: 56
Study 15085374 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoreflex sensitivity (CHRS) measurement after electrical cardioversion
Number of subjects: 43
Study 15085374 — intervention group
Group type: EXPERIMENTAL
Intervention: CHRS below 3.0 ms/mmHg
Number of subjects: 43
Study 15085374 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up after electrical cardioversion
Number of subjects: 43
Study 11150025 — intervention group
Group type: EXPERIMENTAL
Intervention: unfractionated heparin
Number of subjects: 54
Study 11150025 — intervention group
Group type: EXPERIMENTAL
Intervention: low‐molecular‐weight heparin
Number of subjects: 54
Study 11150025 — intervention group
Group type: EXPERIMENTAL
Intervention: lepirudin
Number of subjects: 54
Study 11150025 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 54
Study 11150025 — intervention group
Group type: EXPERIMENTAL
Intervention: all groups (including placebo)
Number of subjects: 54
Study 9456420 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual lorazepam (1 mg)
Number of subjects: 60
Study 9456420 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablet
Number of subjects: 60
Study 7653747 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125% cetirizine nasal spray
Number of subjects: 360
Study 7653747 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.06% cetirizine nasal spray
Number of subjects: 360
Study 7653747 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% cetirizine nasal spray
Number of subjects: 360
Study 7653747 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 360
Study 7653747 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 360
Study 3670682 — intervention group
Group type: EXPERIMENTAL
Intervention: Thymomodulin (120 mg/die for 20 days/month for 4 months)
Number of subjects: 85
Study 3670682 — intervention group
Group type: EXPERIMENTAL
Intervention: Thymomodulin in association with vaccine (120 mg/die for 20 days/month for 4 months)
Number of subjects: 85
Study 3670682 — intervention group
Group type: COMPARATOR
Intervention: Antibiotic therapy
Number of subjects: 85
Study 3670682 — intervention group
Group type: COMPARATOR
Intervention: Vaccine
Number of subjects: 85
Study 3670682 — intervention group
Group type: COMPARATOR
Intervention: Association of vaccine-thymomodulin
Number of subjects: 85
Study 31128008 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative infusion chemotherapy combined with hyperthermia
Number of subjects: 136
Study 28544926 — intervention group
Group type: EXPERIMENTAL
Intervention: Perspective-taking condition (participants who lost resources)
Number of subjects: 180
Study 28544926 — intervention group
Group type: COMPARATOR
Intervention: High resources condition
Number of subjects: 180
Study 28544926 — intervention group
Group type: COMPARATOR
Intervention: Low resources condition
Number of subjects: 180
Study 28544926 — intervention group
Group type: COMPARATOR
Intervention: Lose resources condition
Number of subjects: 180
Study 28544926 — intervention group
Group type: COMPARATOR
Intervention: Gain resources condition
Number of subjects: 180
Study 25417775 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 1008
Study 25417775 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1008
Study 25417775 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 1008
Study 25417775 — intervention group
Group type: EXPERIMENTAL
Intervention: VTE risk score
Number of subjects: 1008
Study 23537608 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured education protocol on transfer skills by physical and occupational therapists
Number of subjects: 70
Study 23537608 — intervention group
Group type: EXPERIMENTAL
Intervention: Dependent transfer
Number of subjects: 70
Study 23537608 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy services
Number of subjects: 70
Study 21596696 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid artery stenting (CAS)
Number of subjects: 22
Study 21596696 — intervention group
Group type: COMPARATOR
Intervention: Purely diagnostic angiography (Control)
Number of subjects: 22
Study 19425877 — intervention group
Group type: EXPERIMENTAL
Intervention: Open RT-CGM
Number of subjects: 12
Study 19425877 — intervention group
Group type: COMPARATOR
Intervention: Blinded RT-CGM (Control)
Number of subjects: 12
Study 19425877 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 12
Study 19425877 — intervention group
Group type: EXPERIMENTAL
Intervention: SMBG vs RT-CGM
Number of subjects: 12
Study 16966188 — intervention group
Group type: EXPERIMENTAL
Intervention: d-amphetamine
Number of subjects: 101
Study 16966188 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study 12780755 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone (40 mg/m2)
Number of subjects: 19
Study 12780755 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (6.5 mg/m2)
Number of subjects: 19
Study 11214010 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolytic treatment for acute myocardial infarction in left bundle branch block
Number of subjects: 257
Study 11214010 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolytic treatment for acute myocardial infarction in right bundle branch block
Number of subjects: 257
Study 11214010 — intervention group
Group type: EXPERIMENTAL
Intervention: Mortality rates in patients with left bundle branch block
Number of subjects: 257
Study 11214010 — intervention group
Group type: EXPERIMENTAL
Intervention: Mortality rates after one year
Number of subjects: 257
Study 8939767 — intervention group
Group type: COMPARATOR
Intervention: Calcium (Ca)
Number of subjects: 189
Study 8939767 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D+Ca
Number of subjects: 189
Study 8939767 — intervention group
Group type: COMPARATOR
Intervention: 1 of 2 doses of vitamin D+Ca
Number of subjects: 189
Study 8939767 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 189
Study 1548519 — intervention group
Group type: EXPERIMENTAL
Intervention: FAMTX
Number of subjects: 60
Study 1548519 — intervention group
Group type: COMPARATOR
Intervention: EAP
Number of subjects: 60
Study 3976636 — intervention group
Group type: COMPARATOR
Intervention: 10 mg metoclopramide
Number of subjects: 93
Study 3976636 — intervention group
Group type: COMPARATOR
Intervention: 20 mg metoclopramide
Number of subjects: 93
Study 3976636 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 93
Study 3976636 — intervention group
Group type: COMPARATOR
Intervention: Both metoclopramide doses
Number of subjects: 93
Study 31258019 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily iron supplementation at a dose of 2 mg kg-1 from 36 hours of age (N=50, anemic mothers)
Number of subjects: 200
Study 31258019 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily iron supplementation at a dose of 2 mg kg-1 from 36 hours of age (N=50, non-anemic mothers)
Number of subjects: 200
Study 31258019 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily iron supplementation at a dose of 2 mg kg-1 from 36 hours of age (N=50, anemic and non-anemic mothers)
Number of subjects: 200
Study 31258019 — intervention group
Group type: COMPARATOR
Intervention: No iron supplementation (N=50, anemic mothers)
Number of subjects: 200
Study 31258019 — intervention group
Group type: COMPARATOR
Intervention: No iron supplementation (N=50, non-anemic mothers)
Number of subjects: 200
Study 31258019 — intervention group
Group type: COMPARATOR
Intervention: No iron supplementation (N=50, anemic and non-anemic mothers)
Number of subjects: 200
Study 31707815 — intervention group
Group type: EXPERIMENTAL
Intervention: Erenumab (70 mg or 140 mg)
Number of subjects: 2375
Study 31707815 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2375
Study 30003634 — intervention group
Group type: EXPERIMENTAL
Intervention: Approach-Avoidance Training (AAT)
Number of subjects: 60
Study 30003634 — intervention group
Group type: EXPERIMENTAL
Intervention: Episodic Future Thinking (EFT)
Number of subjects: 60
Study 30003634 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study 25872790 — intervention group
Group type: EXPERIMENTAL
Intervention: Colistin 4.5 MU as a loading dose, followed by 3 MU every eight hours, combined with levofloxacin
Number of subjects: 496
Study 25872790 — intervention group
Group type: COMPARATOR
Intervention: Meropenem 2 g every eight hours, combined with levofloxacin
Number of subjects: 496
Study 24225149 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care + smartphone application (Glucose Buddy) with weekly text-message feedback from a Certified Diabetes Educator
Number of subjects: 72
Study 24225149 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 72
Study 21128980 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous bone graft (Group A)
Number of subjects: 46
Study 21128980 — intervention group
Group type: COMPARATOR
Intervention: No bone graft (Group B)
Number of subjects: 46
Study 19561523 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-week repeat pulmonary rehabilitation (PR) program
Number of subjects: 60
Study 19561523 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 60
Study 17405970 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan-naproxen sodium (85 mg sumatriptan and 500 mg naproxen sodium)
Number of subjects: 2956
Study 17405970 — intervention group
Group type: COMPARATOR
Intervention: Sumatriptan monotherapy
Number of subjects: 2956
Study 17405970 — intervention group
Group type: COMPARATOR
Intervention: Naproxen sodium monotherapy
Number of subjects: 2956
Study 17405970 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2956
Study 15234487 — intervention group
Group type: EXPERIMENTAL
Intervention: Female players
Number of subjects: 16
Study 15234487 — intervention group
Group type: COMPARATOR
Intervention: Male players
Number of subjects: 16
Study 11176979 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical latanoprost for 3 months (n = 8)
Number of subjects: 17
Study 11176979 — intervention group
Group type: COMPARATOR
Intervention: Alternative medication for 3 months (n = 9)
Number of subjects: 17
Study 7941592 — intervention group
Group type: EXPERIMENTAL
Intervention: Keyhole Limpet Hemocyanin (KLH)
Number of subjects: 50
Study 7941592 — intervention group
Group type: COMPARATOR
Intervention: Control group (no KLH treatment)
Number of subjects: 50
Study 3282216 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpheniramine
Number of subjects: 40
Study 3282216 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 31707503 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-exercise programme
Number of subjects: 24
Study 29705155 — intervention group
Group type: COMPARATOR
Intervention: Telehealth
Number of subjects: 472
Study 29705155 — intervention group
Group type: COMPARATOR
Intervention: Telephone support
Number of subjects: 472
Study 29705155 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care
Number of subjects: 472
Study 28096393 — intervention group
Group type: EXPERIMENTAL
Intervention: Utility-value intervention with parents
Number of subjects: 0
Study 26817221 — intervention group
Group type: EXPERIMENTAL
Intervention: Laughing training program (3 days/week, 60 minutes/day for 8 weeks)
Number of subjects: 38
Study 26817221 — intervention group
Group type: COMPARATOR
Intervention: Control group (no laughing training)
Number of subjects: 38
Study 23205735 — intervention group
Group type: EXPERIMENTAL
Intervention: Human milk fortification
Number of subjects: 132
Study 23205735 — intervention group
Group type: COMPARATOR
Intervention: Fortified group
Number of subjects: 132
Study 23205735 — intervention group
Group type: EXPERIMENTAL
Intervention: Extremely low birth weight (ELBW) neonates
Number of subjects: 132
Study 21450652 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 24
Study 21450652 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study 18457786 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (FCs with monthly contact from Healthy Eating Coordinator)
Number of subjects: 12
Study 18457786 — intervention group
Group type: COMPARATOR
Intervention: Control group (FCs without monthly contact from Healthy Eating Coordinator)
Number of subjects: 12
Study 17238699 — intervention group
Group type: EXPERIMENTAL
Intervention: Online patient portal providing personalized information (Diabetes-STAR)
Number of subjects: 0
Study 17238699 — intervention group
Group type: COMPARATOR
Intervention: Online patient portal providing generic diabetes self-management information
Number of subjects: 0
Study 12635790 — intervention group
Group type: EXPERIMENTAL
Intervention: Resorbable Shuttle Stop (HC Implants, BV. Leiden, The Netherlands)
Number of subjects: 0
Study 12635790 — intervention group
Group type: COMPARATOR
Intervention: Nonresorbable restrictor of polyethylene (De Puy, UK)
Number of subjects: 0
Study 12635790 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study 11056238 — intervention group
Group type: EXPERIMENTAL
Intervention: Pronucleate (PN) zygotes
Number of subjects: 382
Study 11056238 — intervention group
Group type: COMPARATOR
Intervention: Early-cleavage (EC) embryos
Number of subjects: 382
Study 9298778 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation (20 g daily for 5 days)
Number of subjects: 20
Study 9298778 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 8509527 — intervention group
Group type: EXPERIMENTAL
Intervention: ECT twice a week
Number of subjects: 30
Study 8509527 — intervention group
Group type: COMPARATOR
Intervention: ECT thrice a week
Number of subjects: 30
Study 3434161 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 0.05 mg/kg
Number of subjects: 8
Study 3434161 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 0.15 mg/kg
Number of subjects: 8
Study 28562133 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary nitrate (NO3‐) supplementation (beetroot juice)
Number of subjects: 20
Study 28562133 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 27077574 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional electrical stimulation cycling
Number of subjects: 11
Study 27077574 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise intervention)
Number of subjects: 11
Study 25772212 — intervention group
Group type: EXPERIMENTAL
Intervention: MamaNatalie (MG) - 45 minutes of SVD simulation using an obstetrical abdominal-pelvic model
Number of subjects: 110
Study 25772212 — intervention group
Group type: COMPARATOR
Intervention: Noelle (NG) - 45 minutes of SVD simulation using a high-fidelity, computer-controlled mannequin
Number of subjects: 110
Study 23507132 — intervention group
Group type: EXPERIMENTAL
Intervention: Open ultra‐rapid vitrification (10%/10% and 20%/20% ethylene glycol/dimethylsulphoxide)
Number of subjects: 432
Study 23507132 — intervention group
Group type: COMPARATOR
Intervention: Closed aseptic vitrification (5%/5% ethylene glycol/dimethylsulphoxide)
Number of subjects: 432
Study 23507132 — intervention group
Group type: EXPERIMENTAL
Intervention: Open ultra‐rapid vitrification
Number of subjects: 432
Study 23507132 — intervention group
Group type: COMPARATOR
Intervention: Closed aseptic vitrification
Number of subjects: 432
Study 21090893 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored intervention
Number of subjects: 443
Study 21090893 — intervention group
Group type: COMPARATOR
Intervention: Generic intervention
Number of subjects: 443
Study 18410326 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral extended-release oxybutynin 5 mg once daily
Number of subjects: 50
Study 18410326 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 16368813 — intervention group
Group type: EXPERIMENTAL
Intervention: Frakefamide (FF) 1.22 mg/kg
Number of subjects: 12
Study 16368813 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine (M-large) 0.44 mg/kg
Number of subjects: 12
Study 16368813 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine (M-small) 0.11 mg/kg
Number of subjects: 12
Study 16368813 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Sodium chloride 9 mg/mL)
Number of subjects: 12
Study 12784317 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvast (Julphar, UAE)
Number of subjects: 24
Study 12784317 — intervention group
Group type: COMPARATOR
Intervention: Zocor (MSD, Netherlands)
Number of subjects: 24
Study 10836778 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated blood pressure machines
Number of subjects: 3
Study 8975955 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiber supplement (Plantago Ovata)
Number of subjects: 50
Study 8975955 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 8384054 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural anesthesia
Number of subjects: 47
Study 8384054 — intervention group
Group type: COMPARATOR
Intervention: Spinal anesthesia
Number of subjects: 47
Study 3100309 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciclosporin and prednisone
Number of subjects: 40
Study 3100309 — intervention group
Group type: COMPARATOR
Intervention: Prednisone
Number of subjects: 40
Study 30086434 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical marijuana use
Number of subjects: 307